Home>
US Stocks>
Cogent Biosciences Inc

Cogent Biosciences Inc share price today

(COGT)

Cogent Biosciences Inc share price is $8.89 & ₹752.48 as on 7 Dec 2024, 2.30 'hrs' IST

$8.89

▲

-0.1

(-1.11%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Cogent Biosciences Inc share price in Dollar and Rupees. Guide to invest in Cogent Biosciences Inc from India. Also see the sentimental analysis on Indian investors investing in Cogent Biosciences Inc. Get details on the Indian mutual funds that are investing in Cogent Biosciences Inc. Get Analyst recommendations and forecasts along with all the Cogent Biosciences Inc's financials.

Cogent Biosciences Inc share price movements

$8.89
$9.16
$8.89
0.0%
Downside
Day's Volatility :2.95%
Upside
2.95%
$3.67
$12.61
$8.89
58.72%
Downside
52 Weeks Volatility :70.9%
Upside
29.5%

Cogent Biosciences Inc Returns

Period	Cogent Biosciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-17.9%	-5.7%	0.0%
6 Months	4.53%	-0.8%	0.0%
1 Year	4.05%	9.9%	0.0%
3 Years	3.33%	10.7%	-19.7%

Cogent Biosciences Inc Key Statistics

in dollars & INR

Previous Close	$8.99
Open	$9.01
Today's High	$9.16
Today's Low	$8.89
Market Capitalization	$1.0B
Today's Volume	$1.5M
52 Week High	$12.61
52 Week Low	$3.67
Revenue TTM	$0.0
EBITDA	$-258.0M
Earnings Per Share (EPS)	$-2.49
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-78.47%

How to invest in Cogent Biosciences Inc from India?

It is very easy for Indian residents to invest directly in Cogent Biosciences Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cogent Biosciences Inc stock in both rupees (INR) and dollars (USD). Search for Cogent Biosciences Inc or COGT on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cogent Biosciences Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cogent Biosciences Inc shares which would translate to 0.095 fractional shares of Cogent Biosciences Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Cogent Biosciences Inc

63%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Cogent Biosciences Inc on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 63% more investors are searching Cogent Biosciences Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Cogent Biosciences Inc

Point72 Asset Management, L.P.
9.48%
Kynam Capital Management, LP
8.36%
FMR Inc
7.53%
COMMODORE CAPITAL LP
6.83%
BlackRock Inc
6.60%
TCG Crossover Management, LLC
6.30%

Analyst Recommendation on Cogent Biosciences Inc

Buy

82%Buy

17%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Cogent Biosciences Inc(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cogent Biosciences Inc

What analysts predicted

Upside of 84.07%

Current:

$8.89

Target:

$16.36

Insights on Cogent Biosciences Inc

Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 43.9% return, outperforming this stock by 39.4%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.3% return, outperforming this stock by 29.9%

Cogent Biosciences Inc Technicals Summary

Sell

Neutral

Buy

Cogent Biosciences Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cogent Biosciences Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cogent Biosciences Inc	-14.22%	4.53%	4.05%	3.33%	1392.86%
Regeneron Pharmaceuticals, Inc.	-5.97%	-23.34%	-8.6%	17.41%	110.02%
Biontech Se	11.44%	21.29%	14.9%	-59.29%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.77%	64.08%	48.09%	42.33%	108.61%
Vertex Pharmaceuticals Incorporated	-6.83%	-4.83%	31.35%	122.6%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cogent Biosciences Inc	NA	NA	NA	-2.39	-0.78	-0.44	NA	1.85
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cogent Biosciences Inc	Buy	$1.0B	1392.86%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Cogent Biosciences Inc

unum therapeutics is a cambridge, massachusetts-based cellular therapeutics company ushering in a new wave of innovation in cancer immunotherapy. unum was built to transform cancer treatment through the discovery, development and commercialization of novel antibody-coupled cellular immunotherapies. unum has built an antibody-coupled t-cell receptor (actr) platform that, when combined with tumor-specific antibodies, directs an individual’s cytotoxic t-lymphocytes (ctls) to kill tumor cells. in contrast to other approaches that hit a single target and treat a narrow set of tumors, unum’s approach is not restricted by antigens and may have applications for treating many types of cancers. unum’s vision: a single cell therapy that can augment the activity of multiple antibodies to treat many different cancers. unum's lead program based on actr technology is currently in phase i clinical testing to assess safety and efficacy in certain forms of leukemia and lymphoma. in parallel, unum is act

Organization	Cogent Biosciences Inc
Employees	164
CEO	Mr. Andrew R. Robbins M.B.A.
Industry	Health Technology

Management People of Cogent Biosciences Inc

Name	Title
Mr. Andrew R. Robbins M.B.A.	President, CEO & Director
Dr. John Edward Robinson Ph.D.	Chief Scientific Officer
Dr. Jessica Sachs M.D.	Chief Medical Officer
Mr. John L. Green C.A., CPA	CFO & Principal Accounting Officer
Mr. Brad Barnett	Chief Technology Officer
Ms. Christi Waarich	Senior Director of Investor Relations
Mr. Evan D. Kearns J.D.	Chief Legal Officer & Corporate Secretary
Ms. Erin Schellhammer	Chief People Officer
Mr. Dana R. Martin Pharm.D.	Senior VP of Medical Affairs & Chief Patient Officer
Brad Fell	Senior Vice President of Chemistry

Important FAQs about investing in Cogent Biosciences Inc from India :

What is Cogent Biosciences Inc share price today?

Cogent Biosciences Inc (COGT) share price today is $8.89.

Can Indians buy Cogent Biosciences Inc shares?

Yes, Indians can invest in the Cogent Biosciences Inc (COGT) from India.

With INDmoney, you can buy Cogent Biosciences Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cogent Biosciences Inc at zero transaction cost.

How can I buy Cogent Biosciences Inc shares from India?

It is very easy to buy Cogent Biosciences Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cogent Biosciences Inc be purchased?

Yes, you can buy fractional shares of Cogent Biosciences Inc with INDmoney app.

What are the documents required to start investing in Cogent Biosciences Inc stocks?

To start investing in Cogent Biosciences Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.